Graeme Sloan – Managing Director – Kali Metals (ASX:KM1) is a portfolio of assets that represents one of the largest and most prospective exploration packages across Australia’s world leading hard-rock lithium fields.
Copyright 2024 – Finance News Network
Source: Finance News Network
23 Apr 2021 - Capral Limited (ASX:CAA) Managing Director Tony Dragicevich talks about the company's strong FY20 results despite COVID, its product mix, operating environment and outlook.
Read More24 Feb 2021 - Shaw and Partners Chief Investment Officer Martin Crabb provides an update on the global economy, US stimulus packages, rising bond yields and their implications for investors.
Read More27 Feb 2024 - QX Resources Limited (ASX:QXR) Managing Director Steve Promnitz discusses iron ore results from the company's assets in the Pilbara.
Read More27 Sep 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discusses the appointment of a US distributor for the company's APAS Independence instrument.
Read More23 Sep 2024 - Rob Hattersley, Group Head of Capital at MaxCap Group, provides an overview of the company, discussing the funding gap in the Australian credit market, managing risk, the tailwinds for commercial real estate debt, and opportunities within the residential and logistics property markets.
Read More05 Nov 2024 - Paul Sanger interviews Anthony Noble, CEO of The Calmer Co (ASX:CCO), a leader in sustainable kava production. The Calmer Co aims to become the world's dominant kava company by promoting kava's calming and health benefits while improving the livelihoods of farmers in Fiji through fair pricing and a transparent supply chain.
Read More20 Mar 2023 - Tony Brinker, Institutional Equity Research, Select Equities, discusses what happened with the Silicon Valley Bank, and implications for Australian investors.
Read More30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the company's LAG-3-related therapies, outlining future plans and expected data readouts for Immutep's lead drug, eftilagimod alpha.
Read More24 Oct 2019 - BOTTY Limited Founder & CEO, Cary Gee, talks about his Conversational Commerce solution for merchants and how it leverages existing social messaging platforms to create an integrated customer engagement, analytics, payment and delivery solution.
Read More24 Apr 2020 - Telix Pharmaceuticals (ASX:TLX), Chief Business Officer, David Cade talks about its prostate cancer imaging product, diagnostic and therapeutic products, partners and key priorities for 2020.
Read More
